S1P2 receptor mediates sphingosine-1-phosphate-induced fibronectin expression via MAPK signaling pathway in mesangial cells under high glucose condition

详细信息	查看全文 | 推荐本文 |

• 作者：Weihua Liu^a ; ^b ; ¹ ; Tian Lan^c ; ¹ ; Xi Xie^a ; Kaipeng Huang^a ; Jing Peng^a ; Juan Huang^a ; Xiaoyan Shen^a ; Peiqing Liu^a ; Heqing Huang^a ; ^{huangheq@mail.sysu.edu.cn}
• 关键词：Diabetic nephropathy ; Sphingosine-1-phosphate ; Sphingosine-1-phosphate receptors ; Fibronectin ; Mitogen-activated protein kinase signaling pathway
• 刊名：Experimental Cell Research
• 出版年：2012
• 期刊代码：292_00144827
• 类别：med
• 出版时间：1 May, 2012
• 卷：318
• 期：8
• 页码：936-943
• 文件大小：944 K

摘要

Accumulation of extracellular matrix including fibronectin in mesangium is one of the major pathologic characteristics in diabetic nephropathy. In the current study, we explored role of sphingosine-1-phosphate (S1P) receptor in fibronectin expression and underlying molecular mechanism. Among five S1P receptors the mRNA level of S1P2 receptor was the most abundant in kidney of diabetic rats and mesangial cells under high glucose condition. S1P augmentation of fibronectin was significantly inhibited by S1P2 receptor antagonist JTE-013 and S1P2-siRNA. S1P-stimulated fibronectin expression was remarkably blocked by ERK1/2 inhibitor PD98059 and p38MAPK inhibitor SB203580. Phospho-ERK1/2 and phospho-p38MAPK level induced by S1P were markedly abrogated by JTE-013 and S1P2-siRNA. In conclusion, S1P2 receptor was significantly up-regulated under diabetic condition. S1P2 receptor mediated fibronectin expression through the activation of S1P-S1P2-MAPK (ERK1/2 and p38MAPK) axis in mesangial cells under high glucose condition, suggesting that it might be a potential therapeutic target for diabetic nephropathy treatment.